Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

EquipNet to Discuss Asset Management Systems at Interphex 2014

Published: Friday, March 14, 2014
Last Updated: Friday, March 14, 2014
Bookmark and Share
Visit EquipNet on Booth #1239.

Experts from EquipNet Inc. will be on hand at Interphex 2014 (18-20 March in New York City) to demonstrate and discuss the company’s unique asset management solution.

The industry-leading company is dedicated to the pharmaceutical, biotechnology and chemical markets; helping businesses redeploy or sell idle or surplus analytical instruments, process pilot, laboratory, and packaging equipment.

Asset management has evolved in recent years, with surveys showing companies have, on average, 5% of their assets lying idle. EquipNet has been at the forefront of these changes and now offers its clients a range of workflow and management solutions to aid redeployment or sale of business assets.

Their web-based system, ARMS™ (Asset Redeployment Management System) sits behind a company’s firewall, efficiently tracking and facilitating internally redeployment of equipment that is not being used in its current location.

Where an asset can not be relocated, it can be moved through into one of several sales channels. In every case, EquipNet specialists provide expert knowledge and proven project management skills to deliver a complete service package.

Ben Potenza, VP Marketing at EquipNet, said, “Working with both multinational enterprises as well as small and medium sized companies with a single facility, we provide our clients with options to redeploy or sell surplus plant and equipment to gain a real return on their investment.”

To find out more about EquipNet’s asset management expertise and how pharmaceutical industry companies have benefited, visit EquipNet on Booth #1239.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Therapy Halts Progression of Lou Gehrig’s Disease
Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
UTSW Researchers Identifies How Drugs Alter Pancreatic Cancer Cells
The findings were published in Cell Reports.
Researchers Identify Process that Causes Chronic Neonatal Lung Disease
Study determines how the NLRP3 inflammasome activates the protein Interleukin 1 beta.
Dengue Vaccine Enters Phase 3 Trial
Investigational vaccine to prevent ‘breakbone fever’ developed at NIH.
Trying to Conceive Soon After a Pregnancy Loss May Increase Chances of Live Birth
NIH study finds no reason for delaying pregnancy attempts after a loss without complications.
BRCA1 Deficiency Increases the Sensitivity of Ovarian Cancer Cells to Auranofin
An anti-rheumatic drug could improve the prognosis for ovarian cancer patients exhibiting a deficiency of the DNA repair protein BRCA1, a study suggests.
Shingles Vaccine Helps Protect Older Patients with End-stage Renal Disease
Kaiser Permanente study advances knowledge about safety and effectiveness of vaccine commonly given to older adults.
AMRI Acquires Whitehouse Laboratories
Strategically extends AMRI's analytical offerings in rapidly expanding area of outsourcing services.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!